Literature DB >> 12752466

A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom.

Samden D Lhatoo1, Juliet K Solomon, Andrew W McEvoy, Neil D Kitchen, Simon D Shorvon, Josemir W Sander.   

Abstract

PURPOSE: Of the 30,000 persons in whom epilepsy develops annually in the United Kingdom, in approximately 6000 (20%), intractability develops. Some of these patients will be appropriate for epilepsy surgery. We aimed to estimate the number of patients who should be considered surgical candidates, by extrapolation from a population-based study of prognosis and the number who are receiving epilepsy surgery, by a survey of U.K. neurosurgeons.
METHODS: We identified the number of patients who may eventually require surgery from a prospective cohort of patients with newly diagnosed epilepsy. We identified all U.K. neurosurgeons who had performed any epilepsy surgery in the past year. Each identified surgeon prospectively recorded the number and types of operations carried out for 6 months.
RESULTS: Of newly diagnosed patients each year, 450 (1.5%) may eventually require surgery. Thirty-two respondents (22% of all U.K. neurosurgeons) reported that they performed epilepsy surgery. The 211 operations were carried out in the 6 months surveyed (422 operations annually or 13 per surgeon per year). Temporal lobe resection (77%) was the most common procedure.
CONCLUSIONS: Based on a prevalence of 5/1,000 persons with epilepsy, < or =4,500 patients in the U.K. require epilepsy surgery. Every year, 450 patients with newly diagnosed epilepsy who may eventually require surgery are added to this "surgical pool." At the current annual rate of operations, a large number of refractory patients remain untreated. This is probably partly because many patients are not referred for specialist care and therefore remain underinvestigated.

Entities:  

Mesh:

Year:  2003        PMID: 12752466     DOI: 10.1046/j.1528-1157.2003.46002.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

Review 1.  Future directions for epidemiology in epilepsy.

Authors:  Christine Linehan; José F Tellez-Zenteno; Jorge G Burneo; Anne T Berg
Journal:  Epilepsy Behav       Date:  2011-08-04       Impact factor: 2.937

Review 2.  Epidemiologist's view: Addressing the epilepsy surgery treatment gap with minimally-invasive techniques.

Authors:  Nicholas K Schiltz; Guadalupe Fernandez-Baca Vaca
Journal:  Epilepsy Res       Date:  2018-02-01       Impact factor: 3.045

Review 3.  Imaging in the surgical treatment of epilepsy.

Authors:  John S Duncan
Journal:  Nat Rev Neurol       Date:  2010-09-14       Impact factor: 42.937

4.  Temporal trends in pre-surgical evaluations and epilepsy surgery in the U.S. from 1998 to 2009.

Authors:  Nicholas K Schiltz; Siran M Koroukian; Samden D Lhatoo; Kitti Kaiboriboon
Journal:  Epilepsy Res       Date:  2012-08-02       Impact factor: 3.045

5.  The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data.

Authors:  Adam Strzelczyk; Claudia Griebel; Wolfram Lux; Felix Rosenow; Jens-Peter Reese
Journal:  Front Neurol       Date:  2017-12-22       Impact factor: 4.003

6.  Epilepsy Gene Therapy Using an Engineered Potassium Channel.

Authors:  Albert Snowball; Elodie Chabrol; Robert C Wykes; Tawfeeq Shekh-Ahmad; Jonathan H Cornford; Andreas Lieb; Michael P Hughes; Giulia Massaro; Ahad A Rahim; Kevan S Hashemi; Dimitri M Kullmann; Matthew C Walker; Stephanie Schorge
Journal:  J Neurosci       Date:  2019-02-12       Impact factor: 6.167

7.  Incidence and prevalence of major epilepsy-associated brain lesions.

Authors:  Javier A López-Rivera; Victoria Smuk; Costin Leu; Gaelle Nasr; Deborah Vegh; Arthur Stefanski; Eduardo Pérez-Palma; Robyn Busch; Lara Jehi; Imad Najm; Ingmar Blümcke; Dennis Lal
Journal:  Epilepsy Behav Rep       Date:  2022-02-11

Review 8.  Underutilization of epilepsy surgery: Part I: A scoping review of barriers.

Authors:  Debopam Samanta; Adam P Ostendorf; Erin Willis; Rani Singh; Satyanarayana Gedela; Ravindra Arya; M Scott Perry
Journal:  Epilepsy Behav       Date:  2021-02-18       Impact factor: 2.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.